Related Experiment Video

Updated: Aug 15, 2025

Cardiac Magnetic Resonance Imaging at 7 Tesla
09:14

Cardiac Magnetic Resonance Imaging at 7 Tesla

Published on: January 6, 2019

11.6K

Cardiac Magnetic Resonance in Hypertensive Heart Disease: Time for a New Chapter

Marija Zdravkovic1,2, Slobodan Klasnja1, Maja Popovic1

  • 1University Hospital Medical Center Bezanijska Kosa, 11000 Belgrade, Serbia.

Diagnostics (Basel, Switzerland)
|January 8, 2023
PubMed

Insights

Cardiac magnetic resonance (CMR) offers a comprehensive assessment for hypertensive heart disease, detecting subtle myocardial changes and evaluating fibrosis. It is crucial for managing this common cardiovascular risk factor.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Radiology

Background:

  • Hypertension is a major cardiovascular risk factor, leading to myocardial structural and functional changes.
  • Hypertensive heart disease often presents subclinically, necessitating advanced detection methods.

Purpose of the Study:

  • To provide a comprehensive review of cardiac magnetic resonance (CMR) applications in hypertensive heart disease.
  • To highlight CMR's role in assessing disease severity and guiding therapeutic strategies.

Main Methods:

  • Utilizing cardiac magnetic resonance for detailed assessment of cardiac structure and function.
  • Employing CMR for tissue characterization and myocardial fibrosis quantification.

Main Results:

  • CMR enables accurate measurement of ventricle volumes and function.
  • CMR effectively identifies left ventricle hypertrophy patterns and myocardial fibrosis.
  • CMR can detect subtle, subclinical changes associated with hypertensive heart disease.

Conclusions:

  • Cardiac magnetic resonance is an invaluable tool for evaluating hypertensive heart disease.
  • CMR aids in understanding disease progression and assessing treatment efficacy.
  • Early detection of subclinical changes with CMR is critical for patient management.

Keywords:
cardiac magnetic resonancehypertensionhypertensive heart diseaseleft ventricle hypertrophymyocardial fibrosis

More Related Videos

Quantification of Mouse Heart Left Ventricular Function, Myocardial Strain, and Hemodynamic Forces by Cardiovascular Magnetic Resonance Imaging11:13

Quantification of Mouse Heart Left Ventricular Function, Myocardial Strain, and Hemodynamic Forces by Cardiovascular Magnetic Resonance Imaging

Published on: May 24, 2021

6.5K
Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse12:24

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse

Published on: June 20, 2014

10.0K

Related Concept Videos

Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
77
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
30
Magnetic Resonance Imaging01:24

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
5.4K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
36
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
57
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
481